Replies to post #361476 on Anavex Life Sciences Corp (AVXL)

[markjohn62]

I wonder if treating the insomnia would decrease Alzheimers's agitation.

[BIOChecker4]

Part of Missling’s MO is to always have a new shiny object to distract shareholders from something negative (in this case timelines yet again being stretched) and get them focused on something new and tantalizing.

[Kmadd]

In Pharma trials, is it possible to submit a NDA based on secondary endpoint being successful? Sleep in all of these trials has always been a secondary endpoint, so I'm just wondering based on the hundreds of trial patient's data, in different treatment disorders, would Anavex be able to combine sleep therapy as an NDA?

[peeved]

If that were the case the numbers for improvement/stablization in AD symptoms and cognition would already have been met

Unfortunately nothing is timely with this company. As Doc said likely 2026 for approval. Even sava may beat us to it